News & Events

Research team of QDST’s poster presentation in ECCMID 2019


[Research team of QDST's poster presentation in ECCMID 2019]

The tuberculosis research and development department of QuantaMatrix gave a poster presentation on QDST, an anti-tuberculosis drug susceptibility test system, in the 29th The European Society of Clinical Microbiology and Infectious Disease (ECCMID). The team delivered outcomes from a joint research between QuantaMatrix and the Asan Medical Center under the title of `Clinical evaluation of QMAC DST system with MDR-TB and XDR-TB against first- and second-line drugs’ for about an hour from 1:30 PM on April 14. We express our genuine gratitude towards the delegates who attended the presentation session.

The original text of the poster presentation is archived in eLibrary. (

Awarded winner of Sepsis tender from the Great Orchestra of Christmas Charity – WOŚP in Poland!
dRAST solution receives European CE Marking IVDR
QuantaMatrix signed new distribution partnership with Neo-Science for the UAE market
CEO Interview
QuantaMatrix Newly Listed in KOSDAQ